INFOVALLEY Group of Companies, Unit 1.1, Level 1, Block B, MINES Waterfront Business Park, No 3, Jalan Tasik, 43300 Mines Resort City, Selangor, Malaysia.
Mol Biol Rep. 2012 Jul;39(7):7831-8. doi: 10.1007/s11033-012-1626-8. Epub 2012 Apr 28.
Familial hypercholesterolemia (FH) is a disease implicated with defects in either, Low density lipoprotein receptor gene (LDLR), Apolipoprotein B-100 gene (APOB), the Proprotein convertase subtilisin/kexin type 9 gene (PCSK9) or other related genes of the lipid metabolism pathway. The general characterization of heterozygous FH is by elevated low-density lipoprotein (LDL) cholesterol and early-onset cardiovascular diseases, while the more severe type, the homozygous FH results in extreme elevated levels of LDL cholesterol and usually death of an affected individual by early twenties. We present here a novel non-synonymous, missense mutation in exon 14 of the LDLR gene in two siblings of the Malay ethnicity discovered during an in-house genetic test. We postulate that their elevated cholesterol is due to this novel mutation and they are positive for homozygous FH. This is the first report of a C711Y mutation in patients with elevated cholesterol in Asia.
家族性高胆固醇血症(FH)是一种与低密度脂蛋白受体基因(LDLR)、载脂蛋白 B-100 基因(APOB)、前蛋白转化酶枯草溶菌素/柯萨奇蛋白酶 9 基因(PCSK9)或脂质代谢途径的其他相关基因中的缺陷有关的疾病。杂合子 FH 的一般特征是低密度脂蛋白(LDL)胆固醇升高和早发心血管疾病,而更严重的类型,即纯合子 FH 导致 LDL 胆固醇水平极度升高,通常受影响的个体在二十出头就死亡。我们在此介绍在马来族裔的两兄弟的 LDLR 基因外显子 14 中发现的一种新的非同义、错义突变,这是在内部基因测试中发现的。我们推测他们的胆固醇升高是由于这种新的突变,他们是纯合子 FH 阳性。这是亚洲胆固醇升高患者中 C711Y 突变的首次报告。